Cadila Healthcare reports 73% rise in Q4 consolidated net profit

29 May 2021 Evaluate

Cadila Healthcare has reported results for fourth quarter and year ended March 31, 2021.

The company has reported a fall of 24.96% in its net profit at Rs 464.70 crore for the quarter under review as compared to Rs 619.30 crore for the same quarter in the previous year. Total income of the company decreased by 9.97% at Rs 1,991.90 crore for Q4FY21 as compared Rs 2,212.40 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 73.26% in its net profit at Rs 679 crore for the quarter under review as compared to Rs 391.90 crore for the same quarter in the previous year. Total income of the company increased by 0.26% at Rs 3,806.40 crore for Q4FY21 as compared Rs 3,796.40 crore for the corresponding quarter previous year.

For the year ended March 31, 2021, the company has reported a rise of 4.48% in its net profit at Rs 1476.20 crore as compared to Rs 1412.90 crore for the previous year. Total income of the company increased by 9.34% at Rs 7,869.30 crore for year under review as compared to Rs 7,196.80 crore for year ended March 31, 2020.

For the year ended March 31, 2021, on the consolidated basis, the company has reported a rise of 81.34% in its net profit at Rs 2,133.60 crore as compared to Rs 1176.60 crore for the previous year. Total income of the company increased by 5.38% at Rs 15,139.40 crore for year under review as compared to Rs 14,367 crore for year ended March 31, 2020.

Zydus Lifesciences Share Price

929.05 6.60 (0.72%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×